Witnesses urge Congress to pass Results Act to avert Medicare lab cuts Clinical laboratory leaders told the House Energy and Commerce health subcommittee that outdated data under PAMA threatens steep Medicare cuts to routine tests on Jan. 31 and urged the Results Act to provide representative private‑payer data, guardrails against deep reductions and relief from reporting burdens.

Major cuts to Medicare lab testing could jeopardize access to essential diagnostics, especially in rural areas—time is running out for Congress to act!

Click to read more!

#US #RuralLabs #HealthcareAccess #MedicareReform #CitizenPortal #DiagnosticInnovation

Renal Biomarker Market Size, Trends, Growth Outlook 2035 Renal Biomarker Market growth is projected to reach 5.4 USD billion, at a 7.49% CAGR by driving size, share, top company analysis, segments research, trends and forecast report 2025 to 2035.

🩸🔍 Kidney health decoded! The #RenalBiomarker market is key for early detection & better outcomes. 🧠🧪
📖 Full report: www.marketresearchfuture.com/reports/rena...

#Nephrology #DiagnosticInnovation #KidneyCare

A fresh perspective on cardiovascular health! AngioInsight seeks to employ AI for analyzing angiographic images, uncovering what was previously hidden. #DiagnosticInnovation #cardiosky

How lateral flow tests are becoming a diagnostic gamechanger Familiar from the Covid era, the tests are becoming incredibly versatile, with potential uses including detecting killers such as strokes and sepsisSpeedy finger-prick tests to diagnose strokes trialled...

How lateral flow tests are becoming a diagnostic gamechanger #Science #HealthandMedicine #MedicalTechnology #LateralFlowTests #DiagnosticInnovation #HealthTech